Insignia Financial to be removed from the S&P/ASX 200 Index
Filed with ASX · · 2 pages · English
Earlier from 4DMedical
- 4DMedical receives CE Mark for CT: VQ™, enabling commercial launch across the European Union
- CE Mark for CTVQ and $83M placement to fund EU expansion
- CTVQ deployed at Mayo Clinic
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- S&P DJI Announces March 2026 Quarterly Rebalance
Later from 4DMedical
- GSK contract, UK clearance for CTVQ, and ASX 200 inclusion
- Major publication validates CTVQ for lung surgery
- CTVQ enters US Outpatient Market via SimonMed 170 sites
- 4DMedical creates EU platform via contextflow acquisition
- 4DMedical targets US$2.5B PE market entry for CTVQ
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical